| EGFR |
Gefitinib, Erlotinib Cetuximab, Lapatinib, Afatinib, Neratinib |
| HER2 |
Trastuzumab, Lapatinib, Pertuzumab, T-DM1, Afatinib, Neratinib |
| HER3 |
Sapitinib, MM-121, Patritumab, Canertinib |
| c-Kit |
Imatinib, Nilotinib |
| Met |
Crizotinib, Cabozantinib, Foretinib |
| PDGFRα |
Imatinib, Ponatinib Sorafenib, Pazopanib |
| PDGFRβ |
Imatinib, Sunitinib, Axitinib Sorafenib, Pazopanib |
| Flt3 |
Quizartinib, Sunitinib, Lestaurtinib |
| CSF-1R |
Lucitanib |
| Ret1 |
Cabozantinib, Vandetanib, Regorafenib, Ponatinib, Sunitinib |
| Ret2 |
Cabozantinib, Vandetanib, Regorafenib, Ponatinib, Sunitinib |
| IGF1R |
Figitumumab, Ganitumab, Cixutumumab, Dalotuzumab, Robatumumab |
| VGFR1 |
Pazopanib, Sunitinib, Vatalanib |
| VGFR2 |
Ramucirumab, Pazopanib, Sunitinib, Vandetanib, Regorafenib, Lenvatinib |
| VGFR3 |
Pazopanib, Lenvatinib, Cediranib |
| FAK |
Defactinib, GSK-2256098, PF-562,27, VS-4718 |
| Src |
Dasatinib, Saracatinib, Bosutinib |
| Abl |
Imatinib, Nilotinib, Dasatinib, Ponatinib |
| FGFR1 |
Dovitinib, Lucitanib, BGJ398, AZD4547 |
| FGFR2 |
Dovitinib, Lucitanib, BGJ398, AZD4547 |
| FGFR3 |
Dovitinib, BGJ398, AZD4547 |
| FGFR4 |
BGJ398, AZD4547 |
